Search

Displaying results 8871 - 8880 of 10000 in total
  1. Drug

    MK-0686

    go.drugbank.com/drugs/DB12563
    Investigational

    MK0686 has been used in trials studying the treatment of Osteoarthritis, Pain, Postoperative, and Neuralgia, Postherpetic.

  2. Drug

    Senrebotase

    go.drugbank.com/drugs/DB12626
    Investigational

    Senrebotase has been used in trials studying the treatment of Neuralgia, Postherpetic and Urinary Bladder, Overactive.

  3. Drug

    Betacetylmethadol

    go.drugbank.com/drugs/DB01522
    ExperimentalIllicit

    It is used mainly in the treatment of narcotic dependence. [PubChem]

  4. Drug

    REP8839

    go.drugbank.com/drugs/DB05224
    Experimental

    REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).

  5. Drug

    Guanosine-5'-Monophosphate

    go.drugbank.com/drugs/DB01972
    Experimental

    A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]

  6. Drug

    Uridine monophosphate

    go.drugbank.com/drugs/DB03685
    Investigational

    A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.

  7. Drug

    2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

    go.drugbank.com/drugs/DB08398
    Investigational

    PhIP (2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) has been used in trials studying the basic science of Pancreas Cancer.

  8. Drug

    HT-0712

    go.drugbank.com/drugs/DB11650
    Investigational

    BLX-028914 has been used in trials studying the treatment and basic science of Allergic Rhinitis and Age-Associated Memory Impairment (AAMI).

  9. Drug

    Dactolisib

    go.drugbank.com/drugs/DB11651
    Investigational

    Dactolisib has been used in trials studying the treatment of Cancer, Solid Tumor, Renal Cancer, Breast Cancer, and Cowden Syndrome, among others.

  10. Drug

    Figitumumab

    go.drugbank.com/drugs/DB11685
    Investigational

    Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.